[1]刘英,陈龙华,巩湘浩,等.VEGF与肿瘤的放射治疗[J].国际放射医学核医学杂志,2003,27(4):183-186.
　LIU Ying,CHEN Long-hua,GONG Xiang-hao,et al.VEGF and radiation sensibitity[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):183-186.
点击复制

VEGF与肿瘤的放射治疗(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第4期
页码:
183-186
栏目:
放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
VEGF and radiation sensibitity
作者:
刘英1;  陈龙华1;  巩湘浩2;  吕国士3
1. 510515 广州, 第一军医大学南方医院放射肿瘤科;
2. 421001 衡阳, 湖南省衡阳市中心医院湖南;
3. 510515 广州, 第一军医大学南方医院影像中心
Author(s):
LIU Ying1;  CHEN Long-hua1;  GONG Xiang-hao2;  LÜ Guo-shi3
Nanfang Hospital, First Militouy Medical University, Guangzhou 510515, China
关键词:
血管内皮生长因子; 恶性肿瘤; 放射治疗
Keywords:
vascular endothe lial growth factor; malignant tumors; radiation therapy
分类号:
R817.5
摘要:
肿瘤的VEGF(血管内皮生长因子)表达与肿瘤的生长、侵袭、远处转移密切相关,它反映了接受放射治疗肿瘤的生物学和临床行为。回顾近年来的文献说明:(1)各种不同的肿瘤组织在放疗后均表现为VEGF水平上调。(2)肿瘤的高VEGF表达,提示该肿瘤对放射治疗不敏感,预示着疗效不佳。因此,通过拮抗VEGF表达,可以增强放疗疗效。测定VEGF含量可以评估肿瘤的新生血管生成,并据此对肿瘤进行分类,用于制定个性化放疗方案。
Abstract:
VEGF (vascular endothelial growth factor)is important for tumor growth,local invasion and the distant metastasis.It provides important information about the biology and the clinical behavior of tumors undergoing radiotherapy.This review summarizing the present study reports and suggests: (1)Irradiation can induce VEGF expression in diverse tumor cell types. (2)VEGF can be as a predictive factor of response to radiotherapy.VEGF increases in tumors will be resistant to radiation therapy.Anti-VEGF strategies can be used in combination with radiation therapy,and it can increase the anti-tumor effects of radiation therapy.A classification of tumors according to their VEGF level before therapy can be used into designed individual treatment planning.

参考文献/References:

[1] Koukourakis MI, Giatromanolaki A, Sivridis E,et al.Squamous cell head and neck cancer, evidence of angio genic regeneration during radiotherapy[J]. Anticancer Res,2001, 21(6B): 4301-4309.
[2] GuptaVK, Jaskowiak NT, Beckett MA, et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance[J]. Cancer J, 2002, 8(1): 47-54.
[3] Shimada H, Hoshino T, Okazumi S, et al. Expression of angiogenic factors predicts response to chemoradioth erapy and prognosis of oesophageal squamous cell carcinoma[J].Br J Cancer, 2002, 86(4): 552-557.
[4] Hui EP, Chan AT, Pezzella F, et al. Coexpression of hypoxia-inducible factors 1 alpha and 2 alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival[J].Clin Cancer Res, 2002, 8(8): 2595-2604.
[5] Homer JJ, Greenman J, Stafford ND. The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer, relationship with radioresistance[J].Clin Otolaryngol, 2001, 26(6): 498-504.
[6] Schmitt O, Schubert C, Feyerabend T, et al. Preferential topography of proteins regulating vascularization and apoptosis in a MX1 xenotransplant after treatment with hypoxia, hyperthermia, ifosfamide, and irradiation[J]. Am J Clin Oncol, 2002, 25(4): 325-336.
[7] Linderholm BK, Lindahl T, Holmberg L,et al. The expression of vascular endothelial growth factor corre lates with mutant p53 and poor prognosis in human breast cancer[J]. Cancer Res, 2001, 61(5): 2256-2260.
[8] Johansson M, Brannstrom T, Bergenheim AT, et al. Spatial expression of VEGF-A in human glioma[J]. J Neurooncol,2002, 59(1): 1-6.
[9] Arinaga M, Noguchi T, Takeno S, et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma[J]. Cancer, 2003, 97(2): 457-464.
[10] Ando S, Nojima K, Ishihara H, et al. Induction by carbonion irradiation of the expression of vascular endothelial growth factor in lung carcinoma cells[J]. Int J Radiat Bid,2000, 76(8): 1121-1127.
[11] Katoh O, Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor[J]. Cancer Res,1998, (23): 5565-5569.
[12] Bachtiary B, Selzer E, Knocke TH, et al. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival[J].Cancer Lett, 2002, 179(2): 197-203.
[13] Griffin R J, Williams BW, Wild R, et al. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.[J]. Cancer Res, 2002, 62(6): 1702-1706.
[14] Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation[J]. Cancer Res, 1999, 59(14): 3374-3378.
[15] Ning S, Laird D, Cherrington JM, et al. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation[J]. Radiat Res, 2002, 157(1): 45-51.
[16] Solomon B, Hagekyriakou J, Trivett MK, et al. EGFR blockade with ZD1839("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor[J]. Int J Radiat Oncol Bid Phys,2003, 55(3): 713-723.
[17] Greco O, Marples B, Dachs GU, et al. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation[J].Gene Ther, 2002, 9(20): 1403-1411.

相似文献/References:

[1]刘晓梅,张芳,黄建敏.肿瘤血管生成的SPECT分子显像研究进展[J].国际放射医学核医学杂志,2015,39(2):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
　Liu Xiaomei,Zhang Fang,Huang Jianmin.Research advance on molecular imaging of tumor angiogenesis with SPECT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
[2]杨明福,李前伟.肿瘤血管内皮生长因子受体核素显像研究现状[J].国际放射医学核医学杂志,2010,34(1):19.[doi:10.3760/cma.j.issn.1673-4114.2010.01.005]
　YANG Ming-fu,LI Qian-wei.Review present study on vascular endothelial growth factor receptor imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):19.[doi:10.3760/cma.j.issn.1673-4114.2010.01.005]
[3]夏俊勇,王火强.以血管内皮生长因子及其受体为靶向的肺癌放射性核素显像[J].国际放射医学核医学杂志,2008,32(2):82.
　XIA Jun-yong,WANG Huo-qiang.Lung cancer radionuclide imaging targeting at vascular endothelial growth factor and its receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):82.
[4]章文成,杨占山.VEGF的放射生物学特性及其应用[J].国际放射医学核医学杂志,2005,29(1):33.
　ZHANG Wen-cheng,YANG Zhan-shan.The radiation-biological characteristics and application of vascular endothelial growth factor[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):33.
[5]范我.用于肿瘤治疗的放射性药物[J].国际放射医学核医学杂志,2004,28(1):21.
　FAN Wo.Radiopharmaceuticals for tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):21.
[6]杨柳.组织多肽特异性抗原的临床意义[J].国际放射医学核医学杂志,2003,27(5):216.
　YANG Liu.Clinical value of tissue polypeptide specific antigen[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):216.

备注/Memo

备注/Memo:
收稿日期:2003-03-31
作者简介:刘英(1974-),女,硕士研究生,主要从事肿瘤影像诊断与放射治疗的实验和临床研究;陈龙华(1952-),男,主任,教授,博士生导师,主要从事肿瘤影像诊断与放射治疗的基础和临床研究;巩湘浩(1972-),男,主治医生,主要从事肿瘤内科与放射治疗临床工作;吕国士(1972-),男,硕士研究生,主要从事CT、MRI影像诊断实验及临床研究工作。
更新日期/Last Update: 1900-01-01